ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,015Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 1006

$922K Total Retail Price of All Prescriptions

Rank: 51 out of 1006

735 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 735 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,311 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 499 394 1 1
LISINOPRIL 476 303 2 3
ATORVASTATIN CALCIUM 390 284 3 5
FUROSEMIDE 251 184 4 6
SYNTHROID 247 111 5 42
LEVOTHYROXINE SODIUM 246 183 6 2
AMLODIPINE BESYLATE 237 205 7 4
METFORMIN HCL 230 166 8 10
METOPROLOL TARTRATE 210 158 9 7
OMEPRAZOLE 205 137 10 9
CRESTOR 196 130 11 18
ZOLPIDEM TARTRATE 194 114 12 14
HYDROCODONE-ACETAMINOPHEN 169 72 S3 13 25
HYDROCHLOROTHIAZIDE 158 137 14 11
NEXIUM 157 91 15 28
METOPROLOL SUCCINATE 154 106 16 12
GLIPIZIDE 119 100 17 69
GABAPENTIN 119 30 17 20
PANTOPRAZOLE SODIUM 109 75 19 32
OXYCODONE HCL 106 24 S2 20 54
CITALOPRAM HBR 103 82 21 24
ZETIA 103 87 21 51
WARFARIN SODIUM 98 63 23 8
SINGULAIR 89 60 24 82
ATENOLOL 88 72 25 13
TOPIRAMATE 87 17 26 162
DIOVAN 85 69 27 16
ADVAIR DISKUS 83 42 28 37
AZITHROMYCIN 83 52 28 39
LACTULOSE 82 20 30 104
ESCITALOPRAM OXALATE 80 59 31 27
ALENDRONATE SODIUM 79 59 32 29
PLAVIX 77 61 33 61
DIVALPROEX SODIUM 77 15 33 53
LIPITOR 76 54 35 47
DONEPEZIL HCL 74 74 36 17
ACIPHEX 73 24 37 253
TRAMADOL HCL 72 56 38 35
RAMIPRIL 71 68 39 79
ACTONEL 71 11 39 152
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 42 41 38
CHLORHEXIDINE GLUCONATE 69 0 42 136
SPIRIVA 67 34 43 48
OXYCODONE HCL-ACETAMINOPHEN 67 15 S2 43 138
LOSARTAN POTASSIUM 66 64 45 22
CLOPIDOGREL 63 45 46 46
FENOFIBRATE 60 29 47 109
PRAVASTATIN SODIUM 60 44 47 15
CARBAMAZEPINE 58 0 49 124
CIPROFLOXACIN HCL 58 46 49 75
VESICARE 56 14 51 163
DOXAZOSIN MESYLATE 56 51 51 87
TRAZODONE HCL 56 26 51 21
PREDNISONE 56 34 51 33
TAMSULOSIN HCL 55 41 55 23
LANTUS 55 29 55 43
MONTELUKAST SODIUM 54 30 57 125
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 23 58 118
POTASSIUM CHLORIDE 52 27 59 30
SERTRALINE HCL 52 25 59 19
TRILIPIX 51 23 61 185
CYMBALTA 51 11 61 41
PAROXETINE HCL 51 34 61 62
CARBIDOPA-LEVODOPA 50 38 64 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.